New clinical trial designs in the era of precision medicine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New clinical trial designs in the era of precision medicine

Published:2019-02-22 Issue:3 Volume:13 Page:549-557
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Garralda Elena¹²,Dienstmann Rodrigo¹³,Piris‐Giménez Alejandro¹,Braña Irene¹²,Rodon Jordi¹⁴,Tabernero Josep¹

Affiliation:

1. Medical Oncology Department Vall d'Hebron University Hospital and Institute of Oncology (VHIO) Universitat Autònoma de Barcelona Spain

2. Early Drug Development Unit (UITM) Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain

3. Oncology Data Science (ODysSey) Group Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain

4. MD Anderson Cancer Center Houston USA

Funder

Fundación Cellex

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12465

Reference40 articles.

1. Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS , and NRAS (FOCUS4-D): a phase 2–3 randomised trial

2. Twenty‐five years of confirmatory adaptive designs: opportunities and pitfalls

3. Tumour heterogeneity in the clinic

4. Research methods to change clinical practice for patients with rare cancers

5. Evolution of early phase clinical trials in oncology

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision psychiatry: predicting predictability;Psychological Medicine;2024-03-18

2. Can precision medicine be integrated into routine therapeutic decisions at the bedside of patients?;Therapies;2023-12

3. Klinische Genom- und Transkriptomsequenzierung;Forum;2023-11-14

4. A Strategy Utilizing Protein–Protein Interaction Hubs for the Treatment of Cancer Diseases;International Journal of Molecular Sciences;2023-11-08

5. Comment faire entrer la médecine de précision dans la décision thérapeutique de routine au lit du malade ?;Therapies;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3